SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

x402jobs

x402jobs ($JOBS) is trending amid community excitement and speculation about its potential. Discussions center on its low market cap and revenue-sharing model, with many anticipating significant growth.

ARB IOT Group Ltd. is a holding company that engages in the provision of solutions for the integration of IoT systems and devices. It operates through the Internet of Things and Investment Holding and Others segments. The company was founded on March 1, 2022 and is headquartered in Singapore.

ARB IOT Group Ltd

ARBB is trending due to speculation around a potential short squeeze, fueled by its small float and analyst target prices. Community discussions compare it to past runners like $SMX, anticipating a similar explosive move. Traders are closely watching key price levels, particularly the $8 mark, as a breakout point for further upward momentum.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the Materials and Magnetics segments. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

MP is trending due to an Overweight upgrade from Morgan Stanley, citing the company's key role in the U.S. push for a domestic rare earth supply chain and a raised price target. Community discussions revolve around the potential benefits from U.S. efforts to reduce critical mineral dependence, with some highlighting strategic partnerships and government support, while others express concern about stock manipulation and await further catalysts.

Spruce Biosciences, Inc. is a biopharmaceutical company, which engages in developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. The company was founded on November 13, 2014 and is headquartered in South San Francisco, CA.

Spruce Biosciences Inc

SPRB is trending due to community discussion around a recent financing announcement and its potential impact on the stock's future. Some traders are comparing SPRB's volatility and past performance to other low-float biotech stocks, while others discuss potential price targets and short squeeze opportunities. The community is also noting the involvement of a controversial figure, Martin Shkreli, and his potential influence on the stock.

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

Galectin Therapeutics Inc

GALT is trending as community members discuss the potential for partnerships and buyout opportunities following promising trial data. The discussion is centered around the possibility of accelerated FDA approval and the potential for a significant buyout offer, with some speculating on the involvement of major pharmaceutical players. Community members are also referencing 

FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993, and is headquartered in San Francisco, CA.

FibroGen Inc

FibroGen is trending as the community discusses recent insider buying and the potential for a near-term catalyst from their oncology program. Chatter revolves around the company's financial position following the sale of its China operations and upcoming decisions regarding a reverse stock split. Community members are weighing the prospects for Roxadustat and the company's pipeline in the face of continued listing requirements.

BlackRock, Inc. engages in the provision of investment, advisory and risk management solutions. Its products include single-asset and multi-asset portfolios. The company was founded by Laurence Douglas Fink in 1988 and is headquartered in New York, NY.

Blackrock Inc.

BlackRock ($BLK) is trending due to a mix of technical analysis suggesting buying opportunities and analysts updating their ratings to overweight. Community discussions also revolve around BlackRock's potential moves in crypto, including tokenization and Bitcoin ETFs, influencing market sentiment. Additionally, a potential $38 billion deal for AES Corp is generating buzz.

ProShares Trust - ProShares Ultra VIX Short-Term Futures ETF

ProShares Ultra VIX Short-Term Futures ETF

UVXY is trending as traders assess its potential as a hedge against market volatility, especially with upcoming economic data releases and geopolitical concerns. The community is actively discussing entry and exit points, while also weighing the impact of contango and reverse splits on its long-term performance. Despite some skepticism about its leverage and decay, UVXY remains a focal point for those seeking to profit from short-term market swings.

Volatility Shares Trust - 2x Long VIX Futures ETF

Volatility Shares 2x Long VIX Futures ETF

UVIX is trending as traders discuss volatility hedging strategies amid market fluctuations and potential geopolitical risks. Community members are debating the effectiveness of UVIX as a hedge, especially with the VIX experiencing suppressed movement. Discussions also include potential market catalysts like upcoming Fed decisions and Japan's rate policy.

Plasma is the layer 1 blockchain building the stablecoin infrastructure for a new global financial system.   It is purpose-built for global stablecoin payments, offering zero-fee USD₮ transfers and custom gas tokens to help realise the stablecoin promise of permissionless access to financial services for everyone, everywhere.   Plasma’s global payments coverage and inbound suite of products position it as the native chain for stablecoin payments.

Plasma

Plasma (XPL) is seeing volatile discussion as traders debate whether it's reached a bottom after a significant price drop since launch. Sentiment is mixed, with some calling it a scam and others anticipating a recovery, pointing to its underlying technology and potential for real utility in stablecoin transfers. Community chatter also mentions a token unlock event, with some anticipating a potential negative impact on price.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

HighVista Strategies LLC Sells 114,901 Shares of Dynavax Technologies Corporation $DVAX

HighVista Strategies LLC reduced its holdings in shares of Dynavax Technologies Corporation (NASDAQ:DVAX - Free Report) by 48.9% in the 2nd quarter, according to its most recent filing with the...

State Board of Administration of Florida Retirement System Decreases Position in Dynavax Technologies Corporation $DVAX

State Board of Administration of Florida Retirement System lowered its position in Dynavax Technologies Corporation (NASDAQ:DVAX - Free Report) by 81.1% in the second quarter, according to the...

Dynavax Technologies Corporation (NASDAQ:DVAX) Given Consensus Rating of "Hold" by Brokerages

Dynavax Technologies Corporation (NASDAQ:DVAX - Get Free Report) has earned an average recommendation of "Hold" from the five analysts that are covering the stock, MarketBeat.com reports. Two...

Bank of New York Mellon Corp Sells 199,158 Shares of Dynavax Technologies Corporation $DVAX

Bank of New York Mellon Corp lowered its stake in shares of Dynavax Technologies Corporation (NASDAQ:DVAX - Free Report) by 22.4% during the 2nd quarter, according to the company in its most recent...

Dynavax to Participate at the 8th Annual Evercore Healthcare Conference

Dynavax to Participate at the 8th Annual Evercore Healthcare Conference Dynavax to Participate at the 8th Annual Evercore Healthcare Conference PR Newswire EMERYVILLE, Calif., Nov. 19, 2025...

Los Angeles Capital Management LLC Acquires Shares of 32,350 Dynavax Technologies Corporation $DVAX

Los Angeles Capital Management LLC bought a new position in shares of Dynavax Technologies Corporation (NASDAQ:DVAX - Free Report) in the second quarter, according to the company in its most recent...

William Blair Issues Pessimistic Forecast for DVAX Earnings

Dynavax Technologies Corporation (NASDAQ:DVAX - Free Report) - Stock analysts at William Blair decreased their FY2025 earnings per share (EPS) estimates for shares of Dynavax Technologies in a report...

William Blair Issues Optimistic Forecast for DVAX Earnings

Dynavax Technologies Corporation (NASDAQ:DVAX - Free Report) - Analysts at William Blair boosted their Q1 2026 earnings per share (EPS) estimates for shares of Dynavax Technologies in a research note...

Dynavax Technologies (NASDAQ:DVAX) Posts Quarterly Earnings Results, Beats Expectations By $0.07 EPS

Dynavax Technologies (NASDAQ:DVAX - Get Free Report) released its earnings results on Wednesday. The biopharmaceutical company reported $0.21 earnings per share (EPS) for the quarter, beating...

Dynavax Technologies (DVAX) Surpasses Q3 Earnings Estimates

Dynavax Technologies (DVAX) delivered earnings and revenue surprises of +50.00% and -0.23%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the provision of discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Emeryville, CA.

Current Price	$10.80
Prev Close	$10.86
Open	$10.89
Dividend Yield	0.00%
50-Day Moving Average	$10.62
Beta	0.65
Avg. Volume	1.93M
PE Ratio	-28.28

52-Week High	$14.63
52-Week Low	$9.20
Market Capitalization	$1.27B
EPS (Annual)	$0.2048
Price to Book	2.37
Revenue Per Employee	$684,558.03
Enterprise Value/EBITDA	N/A

DVAX
Dynavax Technologies Corp.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest DVAX News

DVAXDynavax Technologies Corp.